Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.

Thomas J. Conlon, Wen Tao Deng, Kirsten Erger, Travis Cossette, Ji jing Pang, Renee Ryals, Nathalie Clément, Brian Cleaver, Issam McDoom, Shannon E. Boye, Marc C. Peden, Mark B. Sherwood, Corinne R. Abernathy, Fowzan S. Alkuraya, Sanford L. Boye, William W. Hauswirth

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.'. Together they form a unique fingerprint.

Medicine & Life Sciences